tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Arcus Biosciences price target raised to $28 from $24 at H.C. Wainwright
PremiumThe FlyArcus Biosciences price target raised to $28 from $24 at H.C. Wainwright
2d ago
Arcus Biosciences Reports Promising Q3 2025 Results
Premium
Company Announcements
Arcus Biosciences Reports Promising Q3 2025 Results
2d ago
Arcus Biosciences reports Q3 EPS ($1.27), consensus ($1.29)
Premium
The Fly
Arcus Biosciences reports Q3 EPS ($1.27), consensus ($1.29)
3d ago
Arcus Biosciences Reports Promising Phase 2 Study Results
PremiumCompany AnnouncementsArcus Biosciences Reports Promising Phase 2 Study Results
17d ago
Arcus Biosciences price target raised to $54 from $47 at Citi
Premium
The Fly
Arcus Biosciences price target raised to $54 from $47 at Citi
18d ago
Positive Outlook for Arcus Biosciences Driven by Promising Phase 2 Trial Results and Broader Patient Applicability
Premium
Ratings
Positive Outlook for Arcus Biosciences Driven by Promising Phase 2 Trial Results and Broader Patient Applicability
18d ago
Truist says Arcus Biosciences data for Casdatifan ‘looks like a home run’
PremiumThe FlyTruist says Arcus Biosciences data for Casdatifan ‘looks like a home run’
25d ago
Arcus Biosciences Presents Promising ARC-20 Study Data
Premium
Company Announcements
Arcus Biosciences Presents Promising ARC-20 Study Data
25d ago
Arcus Biosciences announces new data for casdatifan
Premium
The Fly
Arcus Biosciences announces new data for casdatifan
25d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100